These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19419716)

  • 1. Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction.
    Vilahur G; Casaní L; Peña E; Duran X; Juan-Babot O; Badimon L
    Atherosclerosis; 2009 Sep; 206(1):95-101. PubMed ID: 19419716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model.
    Vilahur G; Casani L; Peña E; Juan-Babot O; Mendieta G; Crespo J; Badimon L
    Int J Cardiol; 2014 Aug; 175(3):528-38. PubMed ID: 25023790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.
    Bulhak A; Roy J; Hedin U; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3158-63. PubMed ID: 17322412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
    Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
    Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
    D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
    Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
    Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction.
    Dourado PM; Tsutsui JM; Landim MB; Casella Filho A; Galvao TF; Aiello VD; Mathias W; da Luz PL; Chagas AC
    Braz J Med Biol Res; 2011 May; 44(5):469-76. PubMed ID: 21445530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats.
    Hu X; Sun A; Xie X; Huang Z; Jia J; Yao R; Ge J
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):162-76. PubMed ID: 23139358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercholesterolemia abrogates the protective effect of ischemic postconditioning by induction of apoptosis and impairment of activation of reperfusion injury salvage kinase pathway.
    Wu N; Zhang X; Jia P; Jia D
    Biochem Biophys Res Commun; 2015 Feb; 458(1):148-53. PubMed ID: 25637532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
    Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
    Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
    Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.
    Ke D; Fang J; Fan L; Chen Z; Chen L
    Coron Artery Dis; 2013 Jun; 24(4):334-41. PubMed ID: 23531479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
    Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.
    Lazou A; Iliodromitis EK; Cieslak D; Voskarides K; Mousikos S; Bofilis E; Kremastinos DT
    Apoptosis; 2006 Dec; 11(12):2195-204. PubMed ID: 17051325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and the response to myocardial injury.
    Scalia R
    Am J Cardiovasc Drugs; 2005; 5(3):163-70. PubMed ID: 15901204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction.
    Vilahur G; Casani L; Juan-Babot O; Guerra JM; Badimon L
    Atherosclerosis; 2012 Oct; 224(2):368-76. PubMed ID: 22882904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
    Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
    Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.